Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.
Identifieur interne : 000B89 ( PubMed/Checkpoint ); précédent : 000B88; suivant : 000B90Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.
Auteurs : Maria Lahuerta ; Yingfeng Wu ; Susie Hoffman ; Batya Elul ; Sarah Gorrell Kulkarni ; Robert H. Remien ; Harriet Nuwagaba-Biribonwoha ; Wafaa El-Sadr ; Denis NashSource :
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [ 1537-6591 ] ; 2014.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Afrique subsaharienne, Antirétroviraux (usage thérapeutique), Femelle, Humains, Infections à VIH (anatomopathologie), Infections à VIH (diagnostic), Infections à VIH (épidémiologie), Jeune adulte, Mâle, Retard de diagnostic (), Retard de diagnostic (tendances), Sujet âgé, Thérapie antirétrovirale hautement active ().
- MESH :
- anatomopathologie : Infections à VIH.
- diagnostic : Infections à VIH.
- tendances : Retard de diagnostic.
- usage thérapeutique : Antirétroviraux.
- épidémiologie : Infections à VIH.
- Adolescent, Adulte, Adulte d'âge moyen, Afrique subsaharienne, Femelle, Humains, Jeune adulte, Mâle, Retard de diagnostic, Sujet âgé, Thérapie antirétrovirale hautement active.
English descriptors
- KwdEn :
- Adolescent, Adult, Africa South of the Sahara, Aged, Anti-Retroviral Agents (therapeutic use), Antiretroviral Therapy, Highly Active (methods), Delayed Diagnosis (statistics & numerical data), Delayed Diagnosis (trends), Female, HIV Infections (diagnosis), HIV Infections (epidemiology), HIV Infections (pathology), Humans, Male, Middle Aged, Young Adult.
- MESH :
- chemical , therapeutic use : Anti-Retroviral Agents.
- geographic : Africa South of the Sahara.
- diagnosis : HIV Infections.
- epidemiology : HIV Infections.
- methods : Antiretroviral Therapy, Highly Active.
- pathology : HIV Infections.
- statistics & numerical data : Delayed Diagnosis.
- trends : Delayed Diagnosis.
- Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Young Adult.
Abstract
Timely antiretroviral therapy (ART) initiation requires early diagnosis of human immunodeficiency virus (HIV) infection with prompt enrollment and engagement in HIV care.
DOI: 10.1093/cid/cit724
PubMed: 24198226
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:24198226Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.</title><author><name sortKey="Lahuerta, Maria" sort="Lahuerta, Maria" uniqKey="Lahuerta M" first="Maria" last="Lahuerta">Maria Lahuerta</name><affiliation><nlm:affiliation>Mailman School of Public Health, ICAP-Columbia University.</nlm:affiliation><wicri:noCountry code="subField">ICAP-Columbia University</wicri:noCountry></affiliation></author><author><name sortKey="Wu, Yingfeng" sort="Wu, Yingfeng" uniqKey="Wu Y" first="Yingfeng" last="Wu">Yingfeng Wu</name></author><author><name sortKey="Hoffman, Susie" sort="Hoffman, Susie" uniqKey="Hoffman S" first="Susie" last="Hoffman">Susie Hoffman</name></author><author><name sortKey="Elul, Batya" sort="Elul, Batya" uniqKey="Elul B" first="Batya" last="Elul">Batya Elul</name></author><author><name sortKey="Kulkarni, Sarah Gorrell" sort="Kulkarni, Sarah Gorrell" uniqKey="Kulkarni S" first="Sarah Gorrell" last="Kulkarni">Sarah Gorrell Kulkarni</name></author><author><name sortKey="Remien, Robert H" sort="Remien, Robert H" uniqKey="Remien R" first="Robert H" last="Remien">Robert H. Remien</name></author><author><name sortKey="Nuwagaba Biribonwoha, Harriet" sort="Nuwagaba Biribonwoha, Harriet" uniqKey="Nuwagaba Biribonwoha H" first="Harriet" last="Nuwagaba-Biribonwoha">Harriet Nuwagaba-Biribonwoha</name></author><author><name sortKey="El Sadr, Wafaa" sort="El Sadr, Wafaa" uniqKey="El Sadr W" first="Wafaa" last="El-Sadr">Wafaa El-Sadr</name></author><author><name sortKey="Nash, Denis" sort="Nash, Denis" uniqKey="Nash D" first="Denis" last="Nash">Denis Nash</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24198226</idno><idno type="pmid">24198226</idno><idno type="doi">10.1093/cid/cit724</idno><idno type="wicri:Area/PubMed/Corpus">001078</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001078</idno><idno type="wicri:Area/PubMed/Curation">001078</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001078</idno><idno type="wicri:Area/PubMed/Checkpoint">001078</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001078</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.</title><author><name sortKey="Lahuerta, Maria" sort="Lahuerta, Maria" uniqKey="Lahuerta M" first="Maria" last="Lahuerta">Maria Lahuerta</name><affiliation><nlm:affiliation>Mailman School of Public Health, ICAP-Columbia University.</nlm:affiliation><wicri:noCountry code="subField">ICAP-Columbia University</wicri:noCountry></affiliation></author><author><name sortKey="Wu, Yingfeng" sort="Wu, Yingfeng" uniqKey="Wu Y" first="Yingfeng" last="Wu">Yingfeng Wu</name></author><author><name sortKey="Hoffman, Susie" sort="Hoffman, Susie" uniqKey="Hoffman S" first="Susie" last="Hoffman">Susie Hoffman</name></author><author><name sortKey="Elul, Batya" sort="Elul, Batya" uniqKey="Elul B" first="Batya" last="Elul">Batya Elul</name></author><author><name sortKey="Kulkarni, Sarah Gorrell" sort="Kulkarni, Sarah Gorrell" uniqKey="Kulkarni S" first="Sarah Gorrell" last="Kulkarni">Sarah Gorrell Kulkarni</name></author><author><name sortKey="Remien, Robert H" sort="Remien, Robert H" uniqKey="Remien R" first="Robert H" last="Remien">Robert H. Remien</name></author><author><name sortKey="Nuwagaba Biribonwoha, Harriet" sort="Nuwagaba Biribonwoha, Harriet" uniqKey="Nuwagaba Biribonwoha H" first="Harriet" last="Nuwagaba-Biribonwoha">Harriet Nuwagaba-Biribonwoha</name></author><author><name sortKey="El Sadr, Wafaa" sort="El Sadr, Wafaa" uniqKey="El Sadr W" first="Wafaa" last="El-Sadr">Wafaa El-Sadr</name></author><author><name sortKey="Nash, Denis" sort="Nash, Denis" uniqKey="Nash D" first="Denis" last="Nash">Denis Nash</name></author></analytic><series><title level="j">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</title><idno type="eISSN">1537-6591</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Africa South of the Sahara</term><term>Aged</term><term>Anti-Retroviral Agents (therapeutic use)</term><term>Antiretroviral Therapy, Highly Active (methods)</term><term>Delayed Diagnosis (statistics & numerical data)</term><term>Delayed Diagnosis (trends)</term><term>Female</term><term>HIV Infections (diagnosis)</term><term>HIV Infections (epidemiology)</term><term>HIV Infections (pathology)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Afrique subsaharienne</term><term>Antirétroviraux (usage thérapeutique)</term><term>Femelle</term><term>Humains</term><term>Infections à VIH (anatomopathologie)</term><term>Infections à VIH (diagnostic)</term><term>Infections à VIH (épidémiologie)</term><term>Jeune adulte</term><term>Mâle</term><term>Retard de diagnostic ()</term><term>Retard de diagnostic (tendances)</term><term>Sujet âgé</term><term>Thérapie antirétrovirale hautement active ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Africa South of the Sahara</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Antiretroviral Therapy, Highly Active</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Delayed Diagnosis</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Retard de diagnostic</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Delayed Diagnosis</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirétroviraux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Afrique subsaharienne</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Retard de diagnostic</term><term>Sujet âgé</term><term>Thérapie antirétrovirale hautement active</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Timely antiretroviral therapy (ART) initiation requires early diagnosis of human immunodeficiency virus (HIV) infection with prompt enrollment and engagement in HIV care.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24198226</PMID><DateCreated><Year>2014</Year><Month>01</Month><Day>14</Day></DateCreated><DateCompleted><Year>2014</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-6591</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title><ISOAbbreviation>Clin. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.</ArticleTitle><Pagination><MedlinePgn>432-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/cit724</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Timely antiretroviral therapy (ART) initiation requires early diagnosis of human immunodeficiency virus (HIV) infection with prompt enrollment and engagement in HIV care.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We examined programmatic data on 334 557 adults enrolling in HIV care, including 149 032 who initiated ART during 2006-2011 at 132 facilities in Kenya, Mozambique, Rwanda, and Tanzania. We examined trends in advanced HIV disease (CD4+ count <100 cells/μL or World Health Organization disease stage IV) and determinants of advanced HIV disease at ART initiation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between 2006-2011, the median CD4+ count at ART initiation increased from 125 to 185 cells/μL an increase of 10 cells/year. Although the proportion of patients initiating ART with advanced HIV disease decreased from 42% to 29%, sex disparities widened. In 2011, the odds of advanced disease at ART initiation were higher among men (adjusted odds ratio [AOR], 1.4; 95% CI, 1.3-1.5), those on tuberculosis treatment (AOR, 1.6; 95% CI, 1.3-2.0), and those with a ≥ 12 month gap in pre-ART care (AOR, 2.0; 95% CI, 1.6-2.6).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Intensified efforts are needed to identify and link HIV-infected individuals to care earlier and to retain them in continuous pre-ART care to facilitate more timely ART initiation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lahuerta</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mailman School of Public Health, ICAP-Columbia University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yingfeng</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Hoffman</LastName><ForeName>Susie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Elul</LastName><ForeName>Batya</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Kulkarni</LastName><ForeName>Sarah Gorrell</ForeName><Initials>SG</Initials></Author><Author ValidYN="Y"><LastName>Remien</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials></Author><Author ValidYN="Y"><LastName>Nuwagaba-Biribonwoha</LastName><ForeName>Harriet</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>El-Sadr</LastName><ForeName>Wafaa</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Nash</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><CollectiveName>Multi-level determinants of late ART initiation in sub-Saharan Africa Team and</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Identifying Optimal Models of HIV Care in sub-Saharan Africa Collaboration</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH089831</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 MH043520</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5U2GPS001537-03</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U2G PS001537</GrantID><Acronym>PS</Acronym><Agency>NCHHSTP CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01MH089831</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>PEPFAR</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Infect Dis</MedlineTA><NlmUniqueID>9203213</NlmUniqueID><ISSNLinking>1058-4838</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044966">Anti-Retroviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Life Sci. 2011 May 23;88(21-22):917-21</RefSource><PMID Version="1">20933522</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antimicrob Chemother. 2013 Jun;68(6):1388-99</RefSource><PMID Version="1">23391713</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>HIV Med. 2004 Mar;5(2):93-8</RefSource><PMID Version="1">15012648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Adv Nurs. 2005 Mar;49(6):616-23</RefSource><PMID Version="1">15737222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Womens Health (Larchmt). 2008 Jan-Feb;17(1):47-55</RefSource><PMID Version="1">18240981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2008 Jul;13(7):870-9</RefSource><PMID Version="1">18373510</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2008 Aug 7;359(6):553-5</RefSource><PMID Version="1">18669420</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2008 Oct 1;22(15):1897-908</RefSource><PMID Version="1">18784453</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2008 Nov 12;22(17):2291-302</RefSource><PMID Version="1">18981768</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2010;5(11):e13801</RefSource><PMID Version="1">21072191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2011 Jun;23(6):764-70</RefSource><PMID Version="1">21293989</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e8-16</RefSource><PMID Version="1">24419071</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2011 Jul 31;25(12):1523-33</RefSource><PMID Version="1">21750418</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2011 Jul;8(7):e1001056</RefSource><PMID Version="1">21811403</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2011 Aug 24;25(13):1657-61</RefSource><PMID Version="1">21673562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2011 Aug 11;365(6):493-505</RefSource><PMID Version="1">21767103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2011 Oct 29;378(9802):1572-9</RefSource><PMID Version="1">21951656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(5):e37125</RefSource><PMID Version="1">22615917</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S78-87</RefSource><PMID Version="1">22797744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Health Care Poor Underserved. 2013 Feb;24(1):359-83</RefSource><PMID Version="1">23377739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(1):e55305</RefSource><PMID Version="1">23383147</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Clin Infect Dis. 2014 Aug 1;59(3):457-8</RefSource><PMID Version="1">24759831</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Clin Infect Dis. 2014 Aug 1;59(3):456-7</RefSource><PMID Version="1">24759825</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017954" MajorTopicYN="N" Type="Geographic">Africa South of the Sahara</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044966" MajorTopicYN="N">Anti-Retroviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023241" MajorTopicYN="N">Antiretroviral Therapy, Highly Active</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057210" MajorTopicYN="N">Delayed Diagnosis</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3890338</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HIV/AIDS</Keyword><Keyword MajorTopicYN="N">advanced HIV disease</Keyword><Keyword MajorTopicYN="N">antiretroviral treatment</Keyword><Keyword MajorTopicYN="N">sub-Saharan Africa</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24198226</ArticleId><ArticleId IdType="pii">cit724</ArticleId><ArticleId IdType="doi">10.1093/cid/cit724</ArticleId><ArticleId IdType="pmc">PMC3890338</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="El Sadr, Wafaa" sort="El Sadr, Wafaa" uniqKey="El Sadr W" first="Wafaa" last="El-Sadr">Wafaa El-Sadr</name><name sortKey="Elul, Batya" sort="Elul, Batya" uniqKey="Elul B" first="Batya" last="Elul">Batya Elul</name><name sortKey="Hoffman, Susie" sort="Hoffman, Susie" uniqKey="Hoffman S" first="Susie" last="Hoffman">Susie Hoffman</name><name sortKey="Kulkarni, Sarah Gorrell" sort="Kulkarni, Sarah Gorrell" uniqKey="Kulkarni S" first="Sarah Gorrell" last="Kulkarni">Sarah Gorrell Kulkarni</name><name sortKey="Lahuerta, Maria" sort="Lahuerta, Maria" uniqKey="Lahuerta M" first="Maria" last="Lahuerta">Maria Lahuerta</name><name sortKey="Nash, Denis" sort="Nash, Denis" uniqKey="Nash D" first="Denis" last="Nash">Denis Nash</name><name sortKey="Nuwagaba Biribonwoha, Harriet" sort="Nuwagaba Biribonwoha, Harriet" uniqKey="Nuwagaba Biribonwoha H" first="Harriet" last="Nuwagaba-Biribonwoha">Harriet Nuwagaba-Biribonwoha</name><name sortKey="Remien, Robert H" sort="Remien, Robert H" uniqKey="Remien R" first="Robert H" last="Remien">Robert H. Remien</name><name sortKey="Wu, Yingfeng" sort="Wu, Yingfeng" uniqKey="Wu Y" first="Yingfeng" last="Wu">Yingfeng Wu</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B89 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000B89 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:24198226
|texte= Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:24198226" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |